Response: Concerns with conclusions in the article by Sherwood et al 'Key differences between 13 KRAS mutation detection technologies and their relevance for clinical practice'

Sustainable Synthesis of Diamide Solvents from Succinic Anhydride under Microwave Conditions for the Production of Graphene via Liquid-Phase Exfoliation.

ACS omega·2026

Enhanced Solvation of Hydrophobic Molecules in Aqueous Cygnet Mixtures Explored Through Their Solubility Isotherms.

Chemphyschem : a European journal of chemical physics and physical chemistry·2026

Predicting pore-carrier solubility and size-exclusivity towards the rational design of type II porous liquid solutions.

Chemical science·2025

AZD2693, a PNPLA3 antisense oligonucleotide, for the treatment of MASH in 148M homozygous participants: Two randomized phase I trials.

Journal of hepatology·2025

Enzymatic synthesis of aromatic biobased polymers in green, low-boiling solvents.

Journal of biotechnology·2024

Correlation of Genogroup I, Genotype 1 (GI.1) Norovirus Neutralizing Antibody Levels With GI.1 Histo-Blood Group Antigen-Blocking Antibody Levels.

The Journal of infectious diseases·2024

Is pembrolizumab as safe and efficient as neoadjuvant treatment in localized dMMR/MSI esophagogastric cancers? Results from the IMHOTEP phase II study.

ESMO open·2026

Liquid biopsy: a new window on the BRCA genes.

ESMO open·2026

Osimertinib in advanced non-small cell lung cancer (NSCLC) harboring different EGFR uncommon variants: real-world data from the Italian biomarker ATLAS database.

ESMO open·2026

Randomised phase III trials of cancer prevention drugs: a systematic review and prediction of trial success.

ESMO open·2026

Pseudoprogression in neoadjuvant immunotherapy for resectable NSCLC: a PET-CT-based study.

ESMO open·2026

Anatomical location defines distinct molecular subtypes of mucosal melanoma.

ESMO open·2026

In vitro and in vivo studies on the impact of the familial adenomatous polyposis heterogeneous mutation MUC20-S671C on colorectal carcinogenesis and progression.

Translational cancer research·2026

Double heterozygous germline pathogenic variants in patients referred to a tertiary cancer genetics clinic in Singapore.

Frontiers in oncology·2026

Correction: Integrative subtyping by bile acid metabolism identifies CLCA1/UGT2A3/ZG16 as markers of immune dysfunction and poor prognosis in colorectal cancer.

Frontiers in oncology·2026

Deconvolution of evolutionary architecture unmasks a high-risk, subclonal-rich subtype in treatment-naive small cell lung cancer.

Journal of thoracic disease·2026

Overexpression of TCF7L2 promotes the viability and migration of MHCC-97H human hepatocellular carcinoma cells by upregulating MT-ND4L.

Translational cancer research·2026

Metabolic reprogramming in diabetes and cancer: the role of PI3K/AKT/mTOR and beyond.

American journal of cancer research·2026

Related Experiment Videos

Response: Concerns with conclusions in the article by Sherwood et al 'Key differences between 13 KRAS mutation

Related Concept Videos

Sustainable Synthesis of Diamide Solvents from Succinic Anhydride under Microwave Conditions for the Production of Graphene via Liquid-Phase Exfoliation.

Enhanced Solvation of Hydrophobic Molecules in Aqueous Cygnet Mixtures Explored Through Their Solubility Isotherms.

Predicting pore-carrier solubility and size-exclusivity towards the rational design of type II porous liquid solutions.

AZD2693, a PNPLA3 antisense oligonucleotide, for the treatment of MASH in 148M homozygous participants: Two randomized phase I trials.

Enzymatic synthesis of aromatic biobased polymers in green, low-boiling solvents.

Correlation of Genogroup I, Genotype 1 (GI.1) Norovirus Neutralizing Antibody Levels With GI.1 Histo-Blood Group Antigen-Blocking Antibody Levels.

Is pembrolizumab as safe and efficient as neoadjuvant treatment in localized dMMR/MSI esophagogastric cancers? Results from the IMHOTEP phase II study.

Liquid biopsy: a new window on the BRCA genes.

Osimertinib in advanced non-small cell lung cancer (NSCLC) harboring different EGFR uncommon variants: real-world data from the Italian biomarker ATLAS database.

Randomised phase III trials of cancer prevention drugs: a systematic review and prediction of trial success.

Pseudoprogression in neoadjuvant immunotherapy for resectable NSCLC: a PET-CT-based study.

Anatomical location defines distinct molecular subtypes of mucosal melanoma.

In vitro and in vivo studies on the impact of the familial adenomatous polyposis heterogeneous mutation MUC20-S671C on colorectal carcinogenesis and progression.

Double heterozygous germline pathogenic variants in patients referred to a tertiary cancer genetics clinic in Singapore.

Correction: Integrative subtyping by bile acid metabolism identifies CLCA1/UGT2A3/ZG16 as markers of immune dysfunction and poor prognosis in colorectal cancer.

Deconvolution of evolutionary architecture unmasks a high-risk, subclonal-rich subtype in treatment-naive small cell lung cancer.

Overexpression of TCF7L2 promotes the viability and migration of MHCC-97H human hepatocellular carcinoma cells by upregulating MT-ND4L.

Metabolic reprogramming in diabetes and cancer: the role of PI3K/AKT/mTOR and beyond.

Related Experiment Videos

Response: Concerns with conclusions in the article by Sherwood et al 'Key differences between 13 KRAS mutation...

Related Concept Videos

Related Articles

Response: Concerns with conclusions in the article by Sherwood et al 'Key differences between 13 KRAS mutation